Cushman & Wakefield today released its Life Sciences Real Estate: A Market Pulse Check on the Chinese Mainland report. This report focuses on a 10-question questionnaire survey we recently conducted on real estate practitioners working for life sciences enterprises on the Chinese mainland. The questions centered on their perspectives and the answers provide the reader with the latest thinking these same real estate practitioners have on the market conditions and have on their current and future real estate strategy to attain business-related success within the Chinese mainland. Some of the findings from the report include:
Business Growth
The tailwinds to business growth on the Chinese mainland are many and include policy, market size, general industry growth, positive population demographic dynamics, and the amount and level of innovation occurring.
Real Estate Expansion
Real estate plays an integral role in the business success of any enterprise, including those operating in the life sciences business arena and making the right choice in terms of the nature and size of an enterprise’s real estate portfolio can often make or break the business.
Location, Cost and Quality
The building location, leasing cost and building quality of each specialized real estate asset associated with a life sciences enterprise have to be considered carefully to ensure business success optimization.
Sustainability
Life sciences enterprises doing business on the Chinese mainland are now very much aware of the concept of environmental, social, and governance (ESG) and many now have their own ESG reporting goals to achieve.
Francis Li, International Director, Vice President, Greater China, Head of Capital Markets, Greater China, said, “Life sciences investors will continue to focus on first-tier cities, major second-tier cities, and in locations where proven track records of solid life sciences business infrastructure and investment are in place.”
Johnathan Wei, President, Project & Occupier Services, China, said, “In the current market environment of cost reduction and efficiency optimization, the location, cost and quality of each specialized real estate asset associated with a life sciences enterprise have to be considered carefully to ensure business success.”
Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, “Lighthouse factories, unmanned factories, and smart factories have been sprouting on the Chinese mainland. As the life sciences industry on the Chinese mainland moves up the value chain, the type of manufacturing space life sciences enterprises will look to secure will increasingly be of higher quality.”
Shaun Brodie, Head of Research Content, Greater China, said, “With the industry tailwinds in play, it’s not surprising that business growth potential on the Chinese mainland spans several life sciences industry sectors and this has not been lost on overseas and domestic life sciences enterprises which will continue to see the Chinese mainland market as an important market globally in terms of market size, talent, innovation and production.”
Please click here to download the full report.
About Cushman & Wakefield
Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In 2023, the firm reported revenue of $9.5 billion across its core services of property, facilities and project management, leasing, capital markets, and valuation and other services. It also receives numerous industry and business accolades for its award-winning culture and commitment to Diversity, Equity and Inclusion (DEI), sustainability and more. For additional information, visit www.cushmanwakefield.com.
